ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
AbbVie Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$282.68−2.74 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $500.63B
- P/E (TTM)
- 79.9
- Dividend yield
- 2.35%
AbbVie Inc. revenue by segment
By business segment
By product or service
By region
From the segment and revenue-disaggregation notes of AbbVie's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.